
ANI PHARMACEUTICALS INC
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
ANI Pharmaceuticals develops, manufactures, and markets branded and generic prescription pharmaceuticals, including specialty products in areas such as rare diseases, and operates its own manufacturing facilities in the United States.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Cook MeredithSR. VP, GENERAL COUNSEL & SEC. | Sell | $37K | 500at $73.59 | Oct 13, 2026 |
| Lalwani NikhilPRESIDENT & CEO | Sell | $401K | 5,400at $74.30 | Aug 25, 2026 |
| Gutwerg OriSVP, GENERICS | Sell | $243K | 3,162at $77.00 | Aug 10, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable ANIP activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.